Invivyd, Inc. (IVVD)
(Delayed Data from NSDQ)
$0.80 USD
+0.04 (5.88%)
Updated Aug 8, 2025 04:00 PM ET
After-Market: $0.80 0.00 (0.26%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth D Momentum F VGM
Fundamental Charts
About Dividend Yield (TTM)
Invivyd, Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
IVVD 0.80 +0.04(5.88%)
Will IVVD be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for IVVD based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for IVVD
Alector (ALEC) Reports Q2 Loss, Tops Revenue Estimates
Royalty Pharma (RPRX) Tops Q2 Earnings and Revenue Estimates
IVVD: What are Zacks experts saying now?
Zacks Private Portfolio Services
Invivyd, Inc. (IVVD) Reports Q1 Loss, Lags Revenue Estimates
Invivyd, Inc. (IVVD) Reports Q4 Loss, Tops Revenue Estimates
Are Investors Undervaluing Invivyd, Inc. (IVVD) Right Now?
Other News for IVVD
Invivyd (IVVD) Welcomes New Expert to SPEAR Study Group | IVVD Stock News
Scientist Dr. Akiko Iwasaki Joins SPEAR Study Group to Investigate Monoclonal Antibodies for ...
Invivyd announces addition of Iwasaki to SPEAR Study Group
Invivyd (IVVD) Gains Momentum with New Monoclonal Antibody Guidelines | IVVD Stock News